BioMerieux Q1 Revenues Up 8 Percent Including BioFire Sales Contribution | GenomeWeb

NEW YORK (GenomeWeb) — BioMérieux today reported a 3 percent increase in first quarter revenues year over year, but an 8 percent increase when including sales from recent acquisition BioFire Diagnostics and at constant exchange rates.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.